ESTIMATION OF LONG‐TERM SURVIVAL WITH TAFASITAMAB + LENALIDOMIDE (LEN) IN RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (R/R DLBCL)

Autor:	Vincenzo Bagnardi, Dan Huang, Debarshi Dey, Mark Winderlich, G.S. Nowakowski, Gilles Salles, B Goswami, Sumeet Ambarkhane
Rok vydání:	2021
Předmět:	Oncology Cancer Research medicine.medical_specialty business.industry Hematology General Medicine medicine.disease Internal medicine Long term survival Relapsed refractory medicine business Diffuse large B-cell lymphoma Lenalidomide medicine.drug
Zdroj:	Hematological Oncology. 39
ISSN:	1099-1069 0278-0232
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::ddc324c08985699083bcb2a89d60ce92 https://doi.org/10.1002/hon.90_2880 Zobrazit plný text záznamu Plný text